Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Melamed

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical and Experimental Immunology|September 1, 1983
The immune system in familial Mediterranean feverI Melamed, Y Shemer, V Zakuth, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Inhibition of lymphocyte response to mitogens by dipyridamole: preliminary findingsI Melamed, A Aviram, A Rubinstein, et al.
American Journal of Diseases of Children (1960)|August 1, 1983
Campylobacter enteritis in normal and immunodeficient childrenI Melamed, Y Bujanover, Y S Igra, et al.
The Journal of Experimental Medicine|March 1, 1995
Nerve growth factor triggers microfilament assembly and paxillin phosphorylation in human B lymphocytesI Melamed, C E Turner, K Aktories, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1989
Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitroZ Spirer, V Zakuth, E Tzehoval, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|October 20, 2004
Laparoscopically guided distal ventriculoperitoneal shunt placementB Kirshtein, M Benifla, A Roy-Shapira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytesR A Franklin, C Brodie, I Melamed, et al.
European Journal of Immunology|September 1, 1996
Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trkI Melamed, C A Kelleher, R A Franklin, et al.
Harefuah|April 1, 1994
[Decreased interleukin-1 and interleukin-2 production after splenectomy]Z Spirer, R Arav-Boger, V Zakuth, et al.
Agents and Actions|November 1, 1981
Histamine content in human kidneys with hypernephroid carcinoma. Is there a pathophysiological mechanism?H J Reimann, R Tauber, P Wendt, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical and Experimental Immunology|September 1, 1983
The immune system in familial Mediterranean feverI Melamed, Y Shemer, V Zakuth, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Inhibition of lymphocyte response to mitogens by dipyridamole: preliminary findingsI Melamed, A Aviram, A Rubinstein, et al.
American Journal of Diseases of Children (1960)|August 1, 1983
Campylobacter enteritis in normal and immunodeficient childrenI Melamed, Y Bujanover, Y S Igra, et al.
The Journal of Experimental Medicine|March 1, 1995
Nerve growth factor triggers microfilament assembly and paxillin phosphorylation in human B lymphocytesI Melamed, C E Turner, K Aktories, et al.
Journal of Clinical & Laboratory Immunology|January 1, 1989
Tuftsin stimulates IL-1 production by human mononuclear cells, human spleen cells and mouse spleen cells in vitroZ Spirer, V Zakuth, E Tzehoval, et al.
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques|October 20, 2004
Laparoscopically guided distal ventriculoperitoneal shunt placementB Kirshtein, M Benifla, A Roy-Shapira, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1995
Nerve growth factor induces activation of MAP-kinase and p90rsk in human B lymphocytesR A Franklin, C Brodie, I Melamed, et al.
European Journal of Immunology|September 1, 1996
Nerve growth factor signal transduction in human B lymphocytes is mediated by gp140trkI Melamed, C A Kelleher, R A Franklin, et al.
Harefuah|April 1, 1994
[Decreased interleukin-1 and interleukin-2 production after splenectomy]Z Spirer, R Arav-Boger, V Zakuth, et al.
Agents and Actions|November 1, 1981
Histamine content in human kidneys with hypernephroid carcinoma. Is there a pathophysiological mechanism?H J Reimann, R Tauber, P Wendt, et al.
Pageof 5